Kuhnert C, Humblot S, Chaouat A, Lalanne H, Pasquali J L, Martin T, Korganow A S
Clinique médicale A, service d'immunologie clinique-médecine interne, Hôpital Civil, 1, place de l'Hôpital, 67000 Strasbourg.
Presse Med. 2002 Jun 1;31(19):885-7.
Langerhans cell pulmonary histiocytosis is a rare disease, primarily enhanced by smoking, and of unclear mechanism.
A 42 year-old man, smoking 25 packs-years, was infected by a type 1 human immunodeficiency virus (HIV-1). He successively developed pulmonary emphysema, Langerhans cell pulmonary histiocytosis and alveolar bronchial carcinoma of the lower right pulmonary lobe, which was fatal.
We discuss the concomitance of pulmonary histiocytosis and alveolar bronchial carcinoma, exceptional in the literature, and the eventual enhancing role of HIV-1 infection. The principal incriminating factor in pulmonary histiocytosis probably remains smoking, but the HIV-1 infection may have participated in the emergence of the neoplastic pathology.